ArticleThe Journal of infectious diseases2025
Clinical Isolates of Antimicrobial-Resistant Enterobacter Species Can Persist in Human Macrophages Without Replication and Overt Cellular Cytotoxicity.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEnterobacter species are opportunistic, multidrug resistant gram-negative bacteria associated with morbidity and mortality worldwide. Because very little is known about the infection biology of Enterobacter spp, we investigated the intracellular trafficking of a subset of Enterobacter clinical isolates, including colistin-resistant strains, within human macrophages and determined the macrophage response to the intracellular infection.
methodsPhagocytosis of 11 clinical isolates representing Enterobacter cloacae, Enterobacter bugandensis, Enterobacter kobei, Enterobacter xiangfangensis, Enterobacter roggenkampii, Enterobacter hoffmannii, and Enterobacter ludwigii was investigated in primary human macrophages. Intracellular bacterial trafficking was followed by confocal fluorescence microscopy, intracellular bacterial replication was assessed by bacterial enumeration, and a fluorescence dilution approach was used to follow bacterial cell division over time. Macrophage cell cytotoxicity was investigated by quantifying the release of lactate dehydrogenase during infection and by determining cleavage of the proinflammatory markers caspase-1, gasdermin D, and prointerleukin-1β.
resultsEnterobacter isolates did not replicate in human macrophages, exhibiting long-term survival (up to 44 hours) within a modified late phagolysosome compartment. Survival did not correlate with colistin resistance, lipopolysaccharide modifications, or bacterial pathogenicity in the Galleria mellonella infection model. Intracellular bacteria induced low levels of macrophage cytotoxicity that correlated with absence of cleavage of proinflammatory markers in infected macrophages.
conclusionsEnterobacter spp clinical isolates can persist without replication inside human macrophages with minimal effects on cell integrity and inflammation. These observations could have implications for clinical outcome of patients that cannot readily clear Enterobacter infections, which can potentially lead to prolonged intracellular survival and infection relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.